Autoimmune lymphoproliferative syndrome - A human disorder of abnormal lymphocyte survival

被引:64
作者
Bleesing, JJH
Straus, SE
Fleisher, TA
机构
[1] NIAID, Dept Lab Med, Warren G Magnuson Clin Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
[3] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA
关键词
D O I
10.1016/S0031-3955(05)70272-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
An important aspect of the immune system is the maintenance of a homeostatic balance between lymphocyte survival and death. This is regulated by apoptosis (programmed cell death). One pathway of this active process of cell suicide is mediated by the lymphocyte receptor Fas (CD95). Its importance in this homeostatic balance is underscored by the consequences of defective Pas-mediated apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS). Abnormal accumulation of lymphocytes results in lymphadenopathy, hepatosplenomegaly, and hypersplenism Failure of removal of potentially autoreactive lymphocytes is associated with the appearance of autoimmune manifestations. Finally, inappropriate survival of lymphocytes may lead to the development of malignancies.
引用
收藏
页码:1291 / +
页数:21
相关论文
共 67 条
  • [1] Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia
    Aspinall, AI
    Pinto, A
    Auer, IA
    Bridges, P
    Luider, J
    Dimnik, L
    Patel, KD
    Jorgenson, K
    Woodman, RC
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 1999, 25 (15) : 227 - 238
  • [2] Bader-Meunier B, 2000, BRIT J HAEMATOL, V108, P300
  • [3] Beltinger C, 1998, BLOOD, V91, P3943
  • [4] Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation
    Benkerrou, M
    LeDeist, F
    deVillartay, JP
    CaillatZucman, S
    RieuxLaucat, F
    Jabado, N
    CavazzanaCalvo, M
    Fischer, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) : 2043 - 2047
  • [5] Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis
    Bettinardi, A
    Brugnoni, D
    QuirosRoldan, E
    Malagoli, A
    LaGrutta, S
    Correra, A
    Notarangelo, LD
    [J]. BLOOD, 1997, 89 (03) : 902 - 909
  • [6] Blanchette V, 1998, SEMIN HEMATOL, V35, P36
  • [7] BROOKS EG, 1990, J IMMUNOL, V144, P4507
  • [8] CHRONIC LYMPHADENOPATHY SIMULATING MALIGNANT LYMPHOMA
    CANALE, VC
    SMITH, CH
    [J]. JOURNAL OF PEDIATRICS, 1967, 70 (06) : 891 - +
  • [9] LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE
    COHEN, PL
    EISENBERG, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 : 243 - 269
  • [10] Chronic lymphoproliferative disorders: An integrated point of view for the differential diagnosis
    D'Arena, G
    Keating, MJ
    Carotenuto, M
    [J]. LEUKEMIA & LYMPHOMA, 2000, 36 (3-4) : 225 - +